Chemerin Novel Biomarker As a Prognostic Factor for Cardiovascular Complications in Type 2 Diabetic Patients

The utility of biomarkers in the discrimination of acute coronary syndrome patients

CARDIAC BIOMARKER PROFILING IN EVALUATION OF RISK IN ACUTE CORONARY SYNDROME

Serum Low Density Lipoprotein and Serum High Sensitive C - Reactive Protein as a Diagnostic Markers for Acute Coronary Syndrome

Evaluation of C-Reactive Protein and CXCL16 in Acute Coronary Syndrome

Diagnostic and Prognostic Utility of FFAR2 Gene Expression in Peripheral Blood as a Potential Biomarker for Acute Coronary Syndrome

Serum Growth Differentiation Factor 15 as a Biomarker for Chronic Heart Failure in Coronary Artery Disease Patients

The Relation Between Serum Chemerin Level and Atherosclerosis in Type II Diabetic Patients with and Without Coronary Artery Disease

Study of Omentin-1 and Chemerin as Predictors of Coronary Artery Disease in Elderly Patients, with Retrospective Studying of their Relation to Diabetes Mellitus Type 2

Sensitivity of Biomarker: Leptin, Adiponectin or High Sensitivity C-reactive protein in diagnosis of Coronary Heart Disease